MedicineBiochemistryOncologyMetabolismMolecular OncologyNeoplasiaCancer MetabolismCytochrome P450 EnzymesCytochrome P450-mediated MetabolismMetabolic ReprogrammingMetabolic Reprogramming In CancerPancreatic CancerArachidonic Acid BiosynthesisArachidonic Acid MetabolitesArachidonic Acid PeroxidationArachidonic Acid SignalingCytochrome P450 Epoxygenase PathwayMetabolic Alterations In CancerRecurrenceTumor Metabolism
OBJECTIVES: Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant digestive tract tumors with a poor prognosis and high recurrence rate. Recently, ferroptosis resistance has been found in PDAC. However, the underlying mechanism of ferroptosis resistance has not been fully elucidated. Cytochrome P450 2J2 (CYP2J2) is the main enzyme which mediates arachidonic acid to produce epoxyeicosatrienoic acids (EETs) in human tissues. It has been reported that EETs involve in the development of cancer, while the roles of EETs in PDAC and ferroptosis remain unclear.This study aims to explore the effect of CYP2J2/EETs on ferroptosis of human pancreatic ductal adenocarcinoma cells PANC-1 cells and the underlying mechanisms. METHODS: concentration, and cell survival were detected. The 8,9-EET was pretreated to observe its effect on erastin-induced ferroptosis in PANC-1 cells. Lentivirus was used to construct a CYP2J2 knockdown cell line to observe its effect on the ferroptosis of PANC-1 cells induced by erastin. A peroxisome proliferation-activated receptor γ (PPARγ) blocker was used to observe the effect of 8,9-EET on erastin-induced glutathione peroxidase 4 (GPX4) and MDA content in PANC-1 cells. RESULTS: concentration, LDH activity and MDA content, and ACSL4 protein expression in erastin-treated PANC-1 cells. The 8,9-EET also restored the ferroportin (FPN) and ferroptosis suppressor protein 1 (FSP1) mRNA expressions in erastin-treated PANC-1 cells. But CYP2J2 knockdown exacerbated the erastin-induced ferroptosis in PANC-1 cells. Besides, CYP2J2 knockdown furtherly down-regulated the gene expression of FPN and FSP1. The 8,9-EET increased the expression of GPX4 in the erastin-treated PANC-1 cells, which was eliminated by a PPARγ blocker GW9662. And GW9662 abolished the anti-ferroptosis effects of 8,9-EET. CONCLUSIONS: CYP2J2/EETs are highly expressed in PDAC tissues. EETs inhibit the ferroptosis via up-regulation of GPX4 in a PPARγ-dependent manner, which contributes to the ferroptosis resistance of PDAC.
28
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Kirill Bersuker, Joseph M. Hendricks, Zhipeng Li et al. · Nature · 2019 · 3.6K citations · Full text
FSP1 is a glutathione-independent ferroptosis suppressor
Sebastian Doll, Florêncio Porto Freitas, Ron Shah et al. · Nature · 2019 · 3.2K citations · Full text
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Michael A. Badgley, Daniel M. Kremer, H. Carlo Maurer et al. · Science · 2020 · 1.3K citations · Full text
Medicine, Cancer Biology, Oncology +15
Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease
Pei Pang, Xiao-Ting Zhou, Fan Hu et al. · Cell Death and Differentiation · 2021 · 662 citations · Full text
Medicine, Neurobiology, Neuroscience +15